Table 3: The incidence of short-term complications of the groin node dissection and their association to study variables.
Cochran Armitage Trend Test, ‡ Pearson Chi Square Test.
Total groins 528 (Total patients 333) No of Groins (No patients) Lymphocyst incidence per groin (per patient) Groin Wound Breakdown incidence per groin (per patient) Groin Wound Infection incidence per groin (per patient)
Variable Number %(%) p value Number % (%) p value Number % (%) p value
Age in years
≤ 50 76 (51) 27 (23) 35.5% (45%) 0.4773† 6 (5) 7.9% (9.8%) 0.4129† 12 (11) 15.8% (21.5%) 0.2701†
51 – 70 179 (112) 64 (55) 35.6% (49%) (0.8274) 11 (11) 6.1% (9.8%) (0.7625) 21 (19) 11.7% (16.9%) (0.4278)
> 70 270 (170) 101 (86) 37.4% (50.5%) 26 (21) 9.6% (12.3%) 23 (22) 8.5% (12.9%)
Smokers
Current 119 (77) 50 (42) 42% (54.5%) 0.2489† 16 (15) 13.4% (19.5%) 0.020‡ 18 (17) 15.1% (22%) 0.2731†
Past 74 (45) 23 (20) 31% (44.4%) (0.4040) 8 (6) 10.8% (13.3%) (0.023) 7 (7) 9.4% (15.5%) (0.2930)
Never 332 (211) 119 (102) 35.8% (48.3%) 19 (16) 5.7% (7.6%) 31 (28) 9.3% (13.3%)
Diabetic
No 451 (286) 159 (138) 35.3% (48.2%) 0.1766† 38 (32) 8.4% (11.2%) 0.3784† 46 (44) 10.2% (15.4%) 0.4600†
Non-Insulin 51 (31) 20 (16) 39.2% (51.6%) (0.5202) 2 (2) 3.9% (6.4%) (0.4657) 8 (6) 15.7% (19.3%) (0.7920)
Insulin 23 (16) 13 (10) 56.5% (62.5%) 3 (3) 13% (18.7%) 2 (2) 8.7% (12.5%)
Nodes removed
≤ 4 nodes 103 (83) 18 (16) 17.5% (19.3%) 0.0001† 2 (2) 1.9% (2.4%) 0.0054† 6 (5) 5.8% (6%) 0.1994†
5 – 8 nodes 168 (148) 56 (57) 33.3% (38.5%) (< 0.0001) 11 (10) 6.5% (6.7%) (0.0047) 22 (22) 13% (14.8%) (0.1645)
9 + nodes 254 (195) 118 (102) 46.4% (52.3%) 30 (27) 11.8% (13.8%) 28 (25) 11% (12.8%)
BMI
< 30 388 (243) 136 (115) 35 (47.3%) 0.191‡ 20 (17) 5.2% (7%) < 0.001‡) 40 (38) 10.3% (15.6%) 0.725‡
≥ 30 137 (90) 56 (49) 40.9% (54.4%) (0.248) 23 (20) 16.8% (22.2%) < 0.001 16 (14) 11.7% (15.5%) (0.985)
Groin Drain
Yes 348 (211) 123 (99) 35.3% (46.9%) 0.854‡ 34 (28) 9.8% (13.3%) 0.064‡ 42 (39) 12.1% (18.6%) 0.155‡
No 177 (122) 69 (65) 39% (52.8%) (0.669) 9 (9) 5.1% (7.4%) (0.094) 14 (13) 7.9% (10.7%) (0.152)